N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Molecular & Cellular Proteomics
- Vol. 20, 100057
- https://doi.org/10.1074/mcp.ra120.002215
Abstract
No abstract availableKeywords
Funding Information
- Leids Universitair Medisch Centrum
This publication has 61 references indexed in Scilit:
- The Identification and Characterization of Novel N-glycan-based Biomarkers in Gastric CancerPLOS ONE, 2013
- The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trialAnnals of Oncology, 2013
- N-glycosylation of Colorectal Cancer TissuesMolecular & Cellular Proteomics, 2012
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based studyThe Lancet Oncology, 2012
- Associated expression of α2,3sialylated type 2 chain structures with lymph node metastasis in distal colorectal cancerSurgery Today, 2012
- Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma CellsOnline Journal of Public Health Informatics, 2011
- Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal CancerJournal of Clinical Oncology, 2011
- High-Mannose Glycans are Elevated during Breast Cancer ProgressionMolecular & Cellular Proteomics, 2011
- Oncotype DX tumor gene expression profiling in stage II colon cancerApplication: Prognostic, risk predictionPLoS Currents, 2010
- High expression of α 2, 3-linked sialic acid residues is associated with the metastatic potential of human gastric cancerCancer Detection Prevention, 2009